Navigation Links
Pseudomembranous in Medical News

ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma com...

ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride

...in is the only approved product to treat Clostridium difficile -associated pseudomembranous colitis, one of the most common and devastating hospital-acquired infection...R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Stap...

ViroPharma Incorporated Reports Second Quarter 2009 Financial Results

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma com...

ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma com...

Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection

...s suffering from CDI, causing the deaths of approximately 300 patients per day. The disease, which can range in severity from mild to severe diarrhea, pseudomembranous colitis, toxic megacolon, sepsis, and death, is costing American healthcare institutions up to $51.5 million per day. "As the leader in molecular...

ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma com...

ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products

...in is the only approved product to treat Clostridium difficile -associated pseudomembranous colitis, one of the most common and devastating hospital-acquired infection...R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Stap...

ViroPharma to Present at Two May Healthcare Conferences

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma com...

ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference

...iroPharma commercializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM...

ViroPharma to Host Investor 'Teach-In' Educational Symposium on Hereditary Angioedema

...iroPharma commercializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM...
Pseudomembranous in Medical Technology

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

...iroPharma commercializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM...

ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance

...roduct to treat Clostridium difficile -associated pseudomembranous colitis. This infection is one of the most common ...inistration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and ente...n some patients treated with Vancocin Capsules for pseudomembranous colitis caused by C. difficile. It is noteworth...

ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients

...iroPharma commercializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM...

FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)

...iroPharma commercializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM...

Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease

...e/ -- Clostridium difficile infection (CDI) is a serious condition that causes disease with a wide spectrum of severity, ranging from mild diarrhea to pseudomembranous colitis and death. Recurrent CDI can occur in up to 20% of patients who develop an initial case of CDI.(1) These patients are at increased risk of add...

ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing in...

ViroPharma Announces Discontinuation of HCV-796 Development

...an specialists and in hospital settings. ViroPharma commercializes Vancocin(R) approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing in...

ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing i...

ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing i...

ViroPharma to Present at the Natixis Bleichroeder Conference

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing i...
Pseudomembranous in Medical Definition

Pathology

... - Diverticulitis - Diverticulosis - IBD ( Crohn's , Ulcerative colitis ) - IBS - Constipation - Colorectal cancer - Hirschsprung's - pseudomembranous colitis Hernia Inguinal - Femoral - Umbilical - Incisional - Diaphragmatic Liver Alcoholic liver disease - Cholestas...
Pseudomembranous in Medical Dictionary

Toxic megacolon

... megacolon occurs as a complication of inflammatory bowel disease, such as ... Toxic megacolon is mainly seen in ulcerative colitis and pseudomembranous ... MedlinePlus Encyclopedia Toxic megacolon . Megacolon in cats. v • d • e ... Toxic megacolon is an infrequent, but potentially fatal c...
Pseudomembranous in Biological News

C. difficile spores spread superbug

...UK in 2007, although, the first a three months of 2009 saw a decline in incidence compared to the same period in 2008. The most severe complication is pseudomembranous colitis, an infection of the colon that can be lethal in patients with weakened immune systems. "What this research essentially provides," says Dr...
Pseudomembranous in Biological Technology

ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma com...

ViroPharma to Present at Two June Healthcare Conferences

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma com...

ViroPharma Incorporated Honored by the National Organization for Rare Disorders

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma com...

ViroPharma Incorporated Reports First Quarter 2009 Financial Results

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma com...

ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009

...iroPharma commercializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM...

ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes

...iroPharma commercializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM...

ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma com...

Sagent Pharmaceuticals Announces Expansion of Cefazolin Product Line to Include Cefazolin for Injection, USP in 500mg Single-Dose Vial

...ommon adverse effects include dark urine, easy bruising/bleeding, irregular heartbeat, seizures, unusual weakness, yellowing eyes or skin, and rarely, pseudomembranous colitis. About Sagent Pharmaceuticals, Inc. Sagent Pharmaceuticals, founded in 2006, is a privately held specialty pharmaceutical compa...

ViroPharma Enhances Leadership to Support Global Growth and Expanding Business

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing in...

ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008

...n specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing in...
Other Tags
(Date:7/24/2014)... (Boston)--Minority women who received the Human Papillomavirus Vaccination ... rates of abnormal Pap test results than those ... the journal Sexually Transmitted Diseases . ... Health and School of Medicine conducted a cross-sectional ... undergoing routine cervical cytology testing. HPV status and ...
(Date:7/24/2014)... On October 24-25th, 2014, hundreds of women ... Embassy Suites LAX North for DiabetesSisters’ power-packed weekend conference. This ... first time it has convened Los Angeles, CA area. It ... open the entire event to both women with diabetes and ... kind worldwide for women with diabetes, the event offers opportunities ...
(Date:7/24/2014)... low-income families vouchers to buy fruits and vegetables at ... foods, according to a new study. Low-income families ... to not having adequate access to healthy foods, cost ... address both of these obstacles, the researchers noted. ... may be able to bring a low-income person onto ...
(Date:7/24/2014)... babies are at risk for autism because they have an ... ways to detect Autism Spectrum Disorder (ASD) earlier in life, ... and how they relate to the possibility and severity of ... the connection between early joint attention before one year and ... communication that develops toward the end of the first year. ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 ACRIA & AMIDA ... BROOKS, , Save the Dates: August 7th ... are excited to cohost “A Dialogue for Life” forums this ... the White House Office of National AIDS Policy (ONAP). This ... efforts being made locally by AIDS organizations, consumers and advocates ...
Breaking Medicine News(10 mins):Health News:DiabetesSisters Brings Conference for Women with Diabetes Los Angeles for the First Time 2Health News:DiabetesSisters Brings Conference for Women with Diabetes Los Angeles for the First Time 3Health News:Farmers' Market Vouchers May Help Poorer Families Eat Healthier 2Health News:Early warning sign for babies at risk of autism 2Health News:White House Office of National AIDS Policy Hosts Public Forums in NYC Aug. 7 and 8, Sponsored by Amida Care and ACRIA 2Health News:White House Office of National AIDS Policy Hosts Public Forums in NYC Aug. 7 and 8, Sponsored by Amida Care and ACRIA 3
(Date:7/23/2014)... Defense recently awarded the STEMPREP Project at Southern ... its goal of increasing the number of minorities ... middle school students for the two-summer classroom phase ... students with summer opportunities at research labs. , ... School of Education and Human Development, boasts an ...
(Date:7/23/2014)... Honey bees, especially the young, are highly sensitive ... together to maintain temperatures within a narrow range. Recently ... at Tufts University,s School of Arts and Sciences, is ... heat within a hive in process similar to how ... vessels and skin. , "This study shows how ...
(Date:7/23/2014)... fur seals, alongside decades of in-depth monitoring, has ... change on a population of top-predators. Published in ... that the seals have significantly altered in accordance ... with climate conditions. Despite a shift in the ... passing down through generations, leaving the population in ...
Breaking Biology News(10 mins):Department of Defense awards $2.6 million grant to SMU STEM program for minority students 2How honey bees stay cool 2Genetic study shows major impact of climate change on Antarctic fur seals 2Genetic study shows major impact of climate change on Antarctic fur seals 3
Other Contents